These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33896035)

  • 21. A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.
    Törlén J; Ringdén O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itälä-Remes M; Remberger M; Mattsson J
    Haematologica; 2016 Nov; 101(11):1417-1425. PubMed ID: 27662016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
    Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major.
    Gauthier A; Bleyzac N; Garnier N; Kebaili K; Joly P; Goutagny MP; Mollet I; Goutelle S; Renard C; Bertrand Y
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2285-2291. PubMed ID: 32007639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.
    Gao L; Liu J; Zhang Y; Chen X; Gao L; Zhang C; Liu Y; Kong P; Zhong J; Sun A; Du X; Su Y; Li H; Liu H; Peng X; Zhang X
    Leuk Res; 2017 Jun; 57():27-36. PubMed ID: 28273549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation.
    Ram R; Storer B; Mielcarek M; Sandmaier BM; Maloney DG; Martin PJ; Flowers ME; Chua BK; Rotta M; Storb R
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):414-22. PubMed ID: 21875504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The safety and efficacy of acute graft-versus-host disease prophylaxis with a higher target blood concentration of cyclosporine around 500 ng/mL.
    Machishima T; Kako S; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Ashizawa M; Terasako K; Kimura S; Kikuchi M; Nakasone H; Kanda J; Yamazaki R; Nishida J; Kanda Y
    Clin Transplant; 2013; 27(5):749-56. PubMed ID: 24033855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.
    García-Martín P; Alarcón-Payer C; López-Fernández E; Moratalla L; Romero A; Sainz J; Ríos R; Jurado M
    Ann Pharmacother; 2015 Sep; 49(9):986-94. PubMed ID: 26160968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transitioning tacrolimus to sirolimus in allogeneic hematopoietic cell transplantation.
    Arrabi L; Jan A; Hosing C; Milton DR; Yeh J
    Eur J Haematol; 2021 Dec; 107(6):634-641. PubMed ID: 34431142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of tacrolimus and cyclosporine combined with methotrexate for graft-versus-host disease prophylaxis, stratified by stem cell source: a retrospective nationwide survey.
    Sakai R; Taguri M; Oshima K; Mori T; Ago H; Adachi S; Morita S; Taniguchi S; Fukuda T; Ohashi K; Eto T; Miyamura K; Iwato K; Kobayashi N; Kanamori H; Morishima Y; Nagamura-Inoue T; Sakamaki H; Atsuta Y; Murata M
    Int J Hematol; 2016 Mar; 103(3):322-33. PubMed ID: 26800676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial tacrolimus weight-based dosing strategy in allogeneic hematopoietic stem-cell transplantation.
    Soskind R; Xiang E; Lewis T; Al-Homsi AS; Papadopoulos J; Cirrone F
    J Oncol Pharm Pract; 2021 Sep; 27(6):1447-1453. PubMed ID: 32957861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].
    Wang J; Song X; Zhang W; Tong S; Hou J; Chen L; Lou J; Li H; Ding X; Min B
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):507-10. PubMed ID: 12133492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward optimization of cyclosporine concentration target to prevent acute graft-versus-host disease following myeloablative allogeneic stem cell transplant.
    Kwan ACF; Blosser N; Ghosh S; Leyshon C; Dersch-Mills D; Puckrin R; Duggan P; Zepeda V; Savoie L; Stewart D; Storek J; Jamani K
    Clin Transplant; 2022 Aug; 36(8):e14732. PubMed ID: 35606904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superior outcome using cyclosporin A alone versus cyclosporin A plus methotrexate for post-transplant immunosuppression in children with acute leukemia undergoing sibling hematopoietic stem cell transplantation.
    Weiss M; Steinbach D; Zintl F; Beck J; Gruhn B
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1089-94. PubMed ID: 25480326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacrolimus-associated posterior reversible encephalopathy syndrome in hematopoietic allogeneic stem cell transplantation.
    Hammerstrom AE; Howell J; Gulbis A; Rondon G; Champlin RE; Popat U
    Am J Hematol; 2013 Apr; 88(4):301-5. PubMed ID: 23460378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporine in combination with mycophenolate mofetil versus methotrexate for graft versus host disease prevention in myeloablative HLA-identical sibling donor allogeneic hematopoietic cell transplantation.
    Hamilton BK; Rybicki L; Dean R; Majhail NS; Haddad H; Abounader D; Hanna R; Sobecks R; Duong H; Hill BT; Copelan E; Bolwell B; Kalaycio M
    Am J Hematol; 2015 Feb; 90(2):144-8. PubMed ID: 25353395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined transplantation of small and large bowel. FK506 versus cyclosporine A in a porcine model.
    Pirenne J; Benedetti E; Gruessner A; Moon C; Hakim N; Fryer JP; Troppmann C; Nakhleh RE; Gruessner RW
    Transplantation; 1996 Jun; 61(12):1685-94. PubMed ID: 8685944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation.
    de Kort EA; de Lil HS; Bremmers MEJ; van Groningen LFJ; Blijlevens NMA; Huls G; Brüggemann RJM; van Dorp S; van der Velden WJFM
    PLoS One; 2019; 14(3):e0213913. PubMed ID: 30897127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
    Zhang WP; Wang JM; Ju XP; Song XM; Tong SP; Li HM
    Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):129-33. PubMed ID: 12697123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enteric-coated mycophenolate sodium containing GvHD prophylaxis reduces GvHD rate after allogeneic HSCT.
    Weber T; Niestadtkötter J; Wienke A; Müller-Tidow C; Müller LP
    Eur J Haematol; 2016 Sep; 97(3):232-8. PubMed ID: 26613546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.